<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lex K</submitter><funding>Howard Hughes Medical Institute</funding><funding>Fondation pour la Recherche Médicale</funding><funding>Ministry of Education and Science | Fundação para a Ciência e a Tecnologia</funding><pagination>15066-15074</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7334448</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(26)</volume><pubmed_abstract>Cancer incidence increases exponentially with age when human telomeres are shorter. Similarly, telomerase reverse transcriptase (&lt;i>tert&lt;/i>) mutant zebrafish have premature short telomeres and anticipate cancer incidence to younger ages. However, because short telomeres constitute a road block to cell proliferation, telomere shortening is currently viewed as a tumor suppressor mechanism and should protect from cancer. This conundrum is not fully understood. In our current study, we report that telomere shortening promotes cancer in a noncell autonomous manner. Using zebrafish chimeras, we show increased incidence of invasive melanoma when wild-type (WT) tumors are generated in &lt;i>tert&lt;/i> mutant zebrafish. Tissues adjacent to melanoma lesions (skin) and distant organs (intestine) in &lt;i>te</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.</pubmed_title><pmcid>PMC7334448</pmcid><funding_grant_id>LISBOA-01-0145-FEDER-022170</funding_grant_id><funding_grant_id>SPF201809007006</funding_grant_id><funding_grant_id>SFRH/BD/52173/2013</funding_grant_id><funding_grant_id>PTDC/BIM-ONC/3402/2014</funding_grant_id><funding_grant_id>PTDC/SAU-ONC/116821/2010</funding_grant_id><funding_grant_id>IECS</funding_grant_id><pubmed_authors>Maia Gil M</pubmed_authors><pubmed_authors>Giannetti K</pubmed_authors><pubmed_authors>Lex K</pubmed_authors><pubmed_authors>Lopes-Bastos B</pubmed_authors><pubmed_authors>Carvalho T</pubmed_authors><pubmed_authors>Marzullo M</pubmed_authors><pubmed_authors>Figueira M</pubmed_authors><pubmed_authors>Ferreira MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.</name><description>Cancer incidence increases exponentially with age when human telomeres are shorter. Similarly, telomerase reverse transcriptase (&lt;i>tert&lt;/i>) mutant zebrafish have premature short telomeres and anticipate cancer incidence to younger ages. However, because short telomeres constitute a road block to cell proliferation, telomere shortening is currently viewed as a tumor suppressor mechanism and should protect from cancer. This conundrum is not fully understood. In our current study, we report that telomere shortening promotes cancer in a noncell autonomous manner. Using zebrafish chimeras, we show increased incidence of invasive melanoma when wild-type (WT) tumors are generated in &lt;i>tert&lt;/i> mutant zebrafish. Tissues adjacent to melanoma lesions (skin) and distant organs (intestine) in &lt;i>te</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2026-07-15T23:26:14.993Z</modification><creation>2025-06-01T12:00:19.497Z</creation></dates><accession>S-EPMC7334448</accession><cross_references><pubmed>32554492</pubmed><doi>10.1073/pnas.1920049117</doi></cross_references></HashMap>